Submission Details
| 510(k) Number | K230887 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 31, 2023 |
| Decision Date | December 21, 2023 |
| Days to Decision | 265 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
K230887 is an FDA 510(k) clearance for the Sysmex XQ-Series (XQ-320) Automated Hematology Analyzer, a Counter, Differential Cell (Class II — Special Controls, product code GKZ), submitted by Sysmex America, Inc. (Lincolnshire, US). The FDA issued a Cleared decision on December 21, 2023, 265 days after receiving the submission on March 31, 2023. This device falls under the Hematology review panel. Regulated under 21 CFR 864.5220.
| 510(k) Number | K230887 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 31, 2023 |
| Decision Date | December 21, 2023 |
| Days to Decision | 265 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
| Product Code | GKZ — Counter, Differential Cell |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.5220 |